cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Seres Therapeutics Inc
12 own
28 watching
Current Price
$0.94
$0.03
(3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
708.92M
52-Week High
52-Week High
6.26000
52-Week Low
52-Week Low
0.54000
Average Volume
Average Volume
3.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization708.92M
icon52-Week High6.26000
icon52-Week Low0.54000
iconAverage Volume3.02M
iconDividend Yield--
iconP/E Ratio--
What does the Seres Therapeutics Inc do?
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed Phase II clinical study to treat multiply recurrent Clostridium difficile infection (CDI). The company also develops SER-287 that is in Phase Ib clinical study in patients with mild-to-moderate ulcerative colitis; and SER-262, a synthetic microbiome therapeutic candidate, which is in Phase Ib study in patients with primary CDI. Its product candidates in pre-clinical development comprise SER-301, a synthetic Ecobiotic microbiome therapeutic candidate for the treatment of inflammatory bowel disease; and SER-155, an Ecobiotic microbiome therapeutic for the prevention of transplant-related mortality. Seres Therapeutics, Inc. has a strategic collaboration with Nestle Health Science and Memorial Sloan Kettering Cancer Center. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Seres Therapeutics Inc make?
News & Events about Seres Therapeutics Inc.
Business Wire
11 months ago
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, has been named to the TIME100 Most Influential Companies, a list of 100 companies making an extraordinary impact around the world. Seres was included within the Pioneers category. To develop the list, TIME solicited...
Business Wire
11 months ago
Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading microbiome therapeutics company, today announced that on June 7, 2023, the Compensation and Talent Committee of Seres board of directors granted inducement equity grants covering an aggregate of 19,400 shares of its common...
Business Wire
11 months ago
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres Therapeutics management, will participate in a question and answer format discussion at the Goldman Sachs Global Healthcare Conference on Monday, June 12, 2023 at 4:40 p.m. PT. An audio...
Business Wire
1 year ago
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on May 9, 2023 at 8:30 a.m. ET to discuss first quarter results and provide a general business update, including initial SER-155...
Business Wire
1 year ago
Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading microbiome therapeutics company, today announced that on April 5, 2023, the Compensation and Talent Committee of Seres board of directors granted inducement equity grants covering an aggregate of 22,000 shares of its common...
Frequently Asked Questions
Frequently Asked Questions
What is Seres Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Seres Therapeutics Inc shares?
plus_minus_icon
How can I buy Seres Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Seres Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Seres Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Seres Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Seres Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Seres Therapeutics Inc?
plus_minus_icon
What percentage is Seres Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Seres Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.94
$0.03
(3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00